![Sublinguale Immuntherapie bei Birkenpollenallergie: weniger Symptome, weniger Zusatzmedikation | SpringerLink Sublinguale Immuntherapie bei Birkenpollenallergie: weniger Symptome, weniger Zusatzmedikation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs15007-021-4950-2/MediaObjects/15007_2021_4950_Fig1_HTML.jpg)
Sublinguale Immuntherapie bei Birkenpollenallergie: weniger Symptome, weniger Zusatzmedikation | SpringerLink
![PDF) Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies PDF) Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies](https://i1.rgstatic.net/publication/342855954_Efficacy_and_safety_of_brexpiprazole_in_patients_with_schizophrenia_presenting_with_severe_symptoms_Post-hoc_analysis_of_short-_and_long-term_studies/links/5f38146792851cd302fa8329/largepreview.png)
PDF) Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies
Conjunctival Provocation Tests: A Predictive Factor for Patients' Seasonal Allergic Rhinoconjunctivitis Symptoms
![Active moiety concentrations following a 4-week treatment interruption... | Download Scientific Diagram Active moiety concentrations following a 4-week treatment interruption... | Download Scientific Diagram](https://www.researchgate.net/profile/Bart-Remmerie/publication/230659162/figure/fig5/AS:202986484703238@1425407157422/Active-moiety-concentrations-following-a-4-week-treatment-interruption-and-reinitiation_Q640.jpg)